Latest Akira Science News & Updates

See the latest news and media coverage for Akira Science. We track all announcements, press releases, and industry mentions in real time, all in one place.

Akira Science

Developer of bioresorbable soft tissue repair implants

akirascience.com

Headquarters: Stockholm, Sweden
Founded year: 2019
Company type: Public company
Number of employees: 2–10

Last updated Today

Latest news about Akira Science

In short: Akira Science progressed its 3D-printed bioresorbable breast cancer scaffolds, secured EU patents, and received an €0.5M EIC Pathfinder award.

Company announcements

May 20 Akira Science

Akira Science pioneers 3D-printed scaffold for breast cancer repair

The AkiMed scaffold is bioresorbable, placed during lumpectomy to support natural tissue regeneration.

May 8 Akira Science

Akira Science receives funding from Medtech4Health

The funding supports external expertise to build the company. Medtech4Health is a Vinnova-funded program accelerating medtech innovations.

March 31 Akira Science

Akira Science celebrates one-year anniversary of AkiMed vision

Q1 2026 milestones include EU/UK patents granted, US filing, and €0.5M EIC Pathfinder award. The company evolves into a commercial MedTech firm.

January 22 Akira Science

Akira Science welcomes Ana Catarina Silva as COO

She brings 15+ years in MedTech and healthtech, focusing on regulatory foundations, quality, and commercialization of their biomaterial platform.

Media coverage

31 March 2025 3D Natives

Akira Science on 3D Printing Biomaterials for Tissue Regeneration - 3Dnatives

We spoke to Akira Science about their work in 3D printing biomaterials for tissue regeneration to help in treatment for diseases like cancer.

Never miss news about Akira Science

Track Akira Science and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.